Garenoxacin pharmacokinetics in subjects with renal impairment

Author： Krishna Gopal Gajjar Diptee Swan Suzanne Marbury Thomas Grasela Dennis M. Wang Zaiqi

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.3, 2007-03, pp. : 649-657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 654-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pharmacokinetics and safety of darapladib in subjects with severe renal impairment

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 654-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 5, 2015-05 ,pp. : 525-533

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of renal impairment on the pharmacokinetics of antimony in hamsters

By Zaghloul I.Y. Al-Jasser M.

Annals of Tropical Medicine and Parasitology, Vol. 98, Iss. 8, 2004-12 ,pp. : 793-800

Maney Publishing

Access to resources Recommend Favorite